Access to data sets, world-leading clinicians, research institutions, key opinion leaders (KOLs), healthcare systems, and technology partners.

Eight years of experience working within the NHS and international hospital systems have provided us with strong access to leading global clinical and research institutions, including key opinion leaders across various therapeutic indications. We leverage these networks to research solutions and ensure clinical validity and innovation within our programmes while ensuring regulatory compliance and adherence to ethical codes of practice.

In-house clinical research and validation team (CRO) to support the development, assessment, and publication of internal or co-developed digital solutions such as biomarkers.

As we’ve begun to develop and launch digital medical solutions, we created an in-house clinical research and validation team to support all aspects of their genesis. Digital healthcare solutions are associated with research which is complex with ever-evolving pathways. Huma is at the forefront of validation protocols in this field.

Established modular software platform comprising of a library of digital biomarkers with data collection functionality.

With the Huma app and web-based platform as our first product, we created a modular software platform comprising of a library of instructional, educational, and data collection activities. These are continually improved through in-house UX, design, and engineering teams.

Experience in, and knowledge of, navigating regulatory pathways within markets such as Europe, the US, and China.

As part of the process for the creation and approval of our platform, we have learnt to navigate regulatory pathways across global markets, for the assessment and approval of software as a medical device to deploy at scale.

Portfolio of integrated devices and external digital solutions to streamline engagement and data collection through a single access point for patient, provider, and biopharma.

We have the ability to connect to thousands of wearables through Apple Health and Google Fit and directly interface with over 500 medical devices to collect data such as blood pressure, heart rate, blood glucose, weight, lung capacity, etc.

Experience in achieving compliance with international reimbursement codes and commercialising digital health solutions in the EMEA, APAC, and US.

Beyond research and development, we directly commercialise our programs with an internal business development function covering healthcare, life sciences, and population health. Projects such as Henry Schein have allowed us to further our experience achieving compliance with international reimbursement codes and commercialising digital health solutions.

Strong partnership and distribution network including Apple, Tencent, China Resources, and Henry Schein, alongside others in healthcare, life sciences, and population health.

Although we are still growing, to extend reach beyond our internal capabilities we have developed strong partnerships and distribution networks. We are one of the only businesses in our field to have such a strong network at the global scale, as well as data storage in-country within all operational markets.